Real-time enrollment status for this compensated cirrhosis clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT06465186 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Compensated Cirrhosis |
| Phase | Clinical Trial |
| Target Enrollment | 80 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | February 2, 2026 (4 weeks ago) |
As of March 2, 2026: Clinical trial NCT06465186 is currently active_not_recruiting participants. This clinical trial study for compensated cirrhosis is not currently accepting new participants at 33 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06465186 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06465186 was last updated 4 weeks ago (February 2, 2026). HelloStudys verifies this status automatically.